Literature DB >> 19211360

[The frequency of cancer in France in 2006, mortality trends since 1950, incidence trends since 1980 and analysis of the discrepancies between these trends].

S Guérin1, F Doyon, C Hill.   

Abstract

In 2006, a total number of 149,000 cancer deaths were observed in France, 88,500 in the male population and 60,500 in the female population. In 2005, the number of new diagnoses of cancer is estimated to be 319,000, 183,000 among men and 136,000 among women. Age-standardised mortality rates are decreasing for most frequent cancer sites, at least in recent years, the main exceptions being lung in the female population, and pancreas in both male and female populations. Age-standardised incidence rate has increased by 38% between 1980 and 2005, when one takes demographic changes into account. This trend is the consequence of the increase in prostate cancer incidence among men and mostly of the increases in breast and lung cancers incidence, among women.

Entities:  

Mesh:

Year:  2009        PMID: 19211360     DOI: 10.1684/bdc.2008.0795

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  5 in total

1.  An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts.

Authors:  Bernard Junod; Per-Henrik Zahl; Robert M Kaplan; Jørn Olsen; Sander Greenland
Journal:  BMC Cancer       Date:  2011-09-21       Impact factor: 4.430

2.  New developments in treatment of ovarian carcinoma: focus on trabectedin.

Authors:  Philippe A Cassier; Aude Duret; Olivier Trédan; Nicolas Carrabin; Pierre Méeus; Isabelle Treilleux; Jean-Paul Guastalla; Isabelle Ray-Coquard
Journal:  Cancer Manag Res       Date:  2010-10-01       Impact factor: 3.989

3.  Cost effectiveness of integrated medicine in patients with cancer receiving anticancer chemotherapy.

Authors:  Romain Coriat; Pascaline Boudou-Rouquette; Jean-Philippe Durand; Priscille Forgeot d'Arc; Idalie Martin; Olivier Mir; Stanislas Ropert; Jérôme Alexandre; François Goldwasser
Journal:  J Oncol Pract       Date:  2012-06-05       Impact factor: 3.840

4.  Therapeutic Efficacy of Alpha-RIT Using a (213)Bi-Anti-hCD138 Antibody in a Mouse Model of Ovarian Peritoneal Carcinomatosis.

Authors:  Aurélie Derrien; Sébastien Gouard; Catherine Maurel; Marie-Hélène Gaugler; Frank Bruchertseifer; Alfred Morgenstern; Alain Faivre-Chauvet; Jean-Marc Classe; Michel Chérel
Journal:  Front Med (Lausanne)       Date:  2015-12-21

5.  Financial risk of increasing the follow-up period of breast cancer treatment currently covered by the Social Protection System in Health in México.

Authors:  Román Rodríguez-Aguilar; José Antonio Marmolejo-Saucedo; Sonia Tavera-Martínez
Journal:  Cost Eff Resour Alloc       Date:  2018-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.